Procore Technologies Form 144 shows ongoing insider share disposals
Rhea-AI Filing Summary
Procore Technologies, Inc. (ticker PCOR) has filed a Form 144 indicating that insider Howard Fu intends to sell 796 common shares through Morgan Stanley Smith Barney on or about 20 June 2025. The proposed sale is valued at approximately $53,236, based on recent market prices, and represents an immaterial 0.0005 % of the company’s 149.2 million shares outstanding.
The filing also discloses a pattern of recent insider sales by the same individual. Over the past three months Mr. Fu has executed seven separate transactions totaling 4,940 shares for aggregate gross proceeds of roughly $318,000. Combined with the newly proposed sale, cumulative dispositions reach 5,736 shares or about $371,000 in value.
All shares being sold were acquired as restricted stock on 20 May 2025 directly from the issuer. No gifts or special payment terms were noted. The filing contains the customary certification that the seller is not in possession of material non-public information.
While the absolute dollar amounts are modest relative to Procore’s market capitalization, continuing insider sales may draw investor attention to executive sentiment. No fundamental financial or operational data were provided in this notice.
Positive
- None.
Negative
- Continued insider selling: Howard Fu has sold or intends to sell a total of 5,736 shares (~$371k) within three months, which may be viewed cautiously by investors even though the amount is small relative to float.
Insights
TL;DR – Minor insider sale of 796 PCOR shares; continuation of small but steady selling trend, unlikely to move the stock.
The Form 144 shows Howard Fu adding another 796 shares (~$53k) to the 4,940 shares already sold since March. In percentage terms the disposal is de minimis versus 149 million shares outstanding, so liquidity and float are unaffected. However, the repeated pattern over a short window may signal personal diversification or tax-planning rather than confidence in near-term upside. There is no indication of 10b5-1 plan adoption, though that field is optional. Because no earnings or strategic data accompany the filing, I classify the event as neutral for valuation. Investors typically monitor insider selling volumes above 1 % of float or clustered multi-executive sales; this filing is far below that threshold.